- Biocept (NASDAQ:BIOC) has partnered with the Foundation for California Community Colleges to make COVID-19 testing available to the 116 California community colleges and their more than 2.1M students.
- Through the Foundation’s CollegeBuys program, Biocept’s PCR-based COVID-19 test is now available for community colleges to purchase for students, faculty and staff.
- Biocept will provide colleges with PCR-based COVID-19 testing, which detects the genetic information of the virus, through its CLIA-certified, CAP-accredited San Diego laboratory.
- Shares down nearly 2% premarket.